NIH RePORTER
Cure8 regulatory brief
Why This Matters
Researchers aim to build and study tiny gut phages (Microviridae) that are largely known only from DNA sequences. Learning how these phages shape microbial communities could help explain virome-linked changes seen in Crohn’s disease and other gut conditions.
Who Should Pay Attention
Researchers studying the microbiome, virome, and phage therapy; clinicians interested in microbiome contributions to IBD and Crohn's disease; patients and advocates tracking basic-science advances that might eventually affect microbiome-based treatments.
Study Snapshot
Story typeRegulatory
Evidence typeFunded research project
Study statusFunded
Source depthResearch project record
What To Know
This is a funded NIH research project proposing to synthesize and experimentally study small single-stranded DNA bacteriophages (Microviridae) assembled from metagenomic data.
The investigators plan to develop reverse-genetic systems to make physical microvirus isolates, probe how these tiny phages compete with larger dsDNA phages, and identify genomic rules that enable host range and evasion of bacterial defenses.
The work is basic and experimental: its immediate outputs will be new lab methods, isolated phages, and mechanistic insights about phage genomes and host interactions.
The proposal suggests longer-term possibilities such as using microviruses or their replicative modules for microbiome manipulation or phage therapy, but those are future aims, not reported results.
If you follow IBD research, the project is relevant because shifts in phage communities (virome) and gut dysbiosis have been linked to obesity, cognition changes, and intestinal disorders including Crohn's disease; this project aims to enable experimental tests of such links by making otherwise inaccessible microviruses available for study.
Keep In Mind
This is a funded NIH project abstract (project-record). It describes proposed laboratory work and goals rather than experimental results. Any clinical or therapeutic implications are speculative at this stage.
Source Details
Review the original publication for the complete reporting, methods, and context.
Funded research project
Evidence type derived from source or registry metadata.
PublicationNIH RePORTER
AuthorsPaul Kirchberger
InstitutionOKLAHOMA STATE UNIVERSITY STILLWATER
Study typeFunded Research Project
Indexed viaNIH RePORTER
Source typeFunded research record
PublishedSep 1, 2026, 12:00 AM
Content availableResearch project record
Funding disclosed by the source: National Institute of General Medical Sciences - R35GM160478 - $373,960
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
AI-augmented analysis sheds new light on Crohn's disease complications
Fibrosis (irreversible bowel scarring) is a major cause of surgery in Crohn’s disease. This study points to molecular and microbiome patterns that may help predict or distinguish fibrosis from active inflammation, which...
AI helps to open new routes to earlier diagnosis and treatment of Crohn's disease
Fibrosis (irreversible bowel scarring) is a major cause of surgery in Crohn’s disease. Identifying molecular and microbial markers tied to fibrosis could eventually help predict who’s at higher risk and guide earlier,...
Site specific gene-microbial interactions in children with early-onset Crohn’s disease
Understanding gene–microbe interactions that drive site-specific disease in very early-onset Crohn’s could reveal why some children develop ileal versus colonic disease and suggest new approaches to prevention or...